Article
Primary Immune Deficiency: Patients’ Preferences for Replacement Immunoglobulin Therapy
2021-05-04
Abstract excerpt
<title>Abstract</title> <p><bold>Purpose:</bold> Immunoglobulin (Ig) replacement therapy is an important life-saving treatment modality for patients with primary antibody immune deficiency disorders (PAD). IVIG and SCIg are suitable alternatives to treat patients with PAD but vary in key ways. Existing evidence on patient preferences for Ig treatments given the complexities associated with IVIG and SCIg treatment...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8c381da6-a8c7-50cd-82bb-f36e1dc053b3
- DOI
- 10.21203/rs.3.rs-397453/v1
